These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 5742338)

  • 1. [Reactogenic activity of C. burneti vaccines. I. Allergenic and toxic properties of phases I and II C. burneti corpuscular vaccines].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):665-78. PubMed ID: 5742338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunogenic value of various phase I Q vaccines prepared from various strains of Coxiella burneti].
    Zarnea G; Crăcea E; Dumitresco S; Novac S; Mihancea N
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):691-6. PubMed ID: 5742340
    [No Abstract]   [Full Text] [Related]  

  • 4. Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.
    Crăcea E; Dumitrescu-Constantinescu S; Botez D; Ioanid L
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):413-8. PubMed ID: 910580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibody response to antigens of Coxiella burneti.
    Fiset P; Ormsbee RA
    Zentralbl Bakteriol Orig; 1968 Apr; 206(3):321-9. PubMed ID: 5707314
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti.
    Robinson DM; Hasty SE
    Appl Microbiol; 1974 Apr; 27(4):777-83. PubMed ID: 4825980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral immune response of goats, rabbits and guinea pigs following vaccination with a Q fever vaccine].
    Schmeer N; Adami M; Döpfer B; Herbst W; Schmuck W
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):20-4. PubMed ID: 3985935
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the immunogenicity of various phases of the Burneti rickettsia].
    Kudelina RI; Fedorova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):17-21. PubMed ID: 5617968
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.
    Kazár J; Brezina R; Palanová A; Tvrdá B; Schramek S
    Bull World Health Organ; 1982; 60(3):389-94. PubMed ID: 6982774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity of an R. burneti strain isolated in Bulgaria].
    Pandŭrov S
    Vet Med Nauki; 1980; 17(1):90-4. PubMed ID: 7414937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of cattle against Q-fever.
    Sádecký E; Brezina R; Michalovic M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):200-6. PubMed ID: 1236883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of the allergenic properties of the soluble antigen of Rickettsia burneti under experimental conditions].
    Kudelina RI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):95-101. PubMed ID: 5790217
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of phase variation on the protective activity of C. burneti vaccines.
    Crăcea E; Dumitrescu S; Novac S; Mihancea N
    Arch Roum Pathol Exp Microbiol; 1966 Dec; 25(4):943-50. PubMed ID: 5983323
    [No Abstract]   [Full Text] [Related]  

  • 14. Local pathogenic effects of Q fever vaccines. Some attempts to diminish the local pathogenic effect of phase I Coxiella burneti corpuscular vaccine.
    Crăcea E; Zarnea G; Dumitrescu S; Botez D; Sabin S
    Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):367-72. PubMed ID: 4665073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phase variations in Coxiella burneti].
    Crăcea E
    Microbiol Parazitol Epidemiol (Bucur); 1967; 12(3):273-81. PubMed ID: 5597258
    [No Abstract]   [Full Text] [Related]  

  • 16. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL; Elliott JJ; Waag DM; Jaax GP
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of purified suspensions of Coxiella burneti by Genetron extraction followed by continuous-flow ultracentrifugation.
    Dubois DR; Cutchins EC; Berman S; Lowenthal JP; Timchak RL
    Appl Microbiol; 1972 May; 23(5):841-5. PubMed ID: 4555634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitation of phase I antigen of Coxiella burnetii by sodium sulfite.
    Wachter RF; Briggs GP; Pedersen CE
    Acta Virol; 1975 Nov; 19(6):500. PubMed ID: 2000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.